#BEGIN_DRUGCARD DB02175

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
141-82-2

# ChEBI_ID:
30794

# Chemical_Formula:
C3H4O4

# Chemical_IUPAC_Name:
propanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-0.81

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
7.63E+005 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Malonic acid

# HET_ID:
MLA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)

# InChI_Key:
InChIKey=OFOBLEOULBTSOW-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00383

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2175

# Mechanism_Of_Action:
Not Available

# Melting_Point:
135 dec °C

# Molecular_Weight_Avg:
104.0615

# Molecular_Weight_Mono:
104.010958616

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1Q44

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.6

# Predicted_LogS:
0.28

# Predicted_Water_Solubility:
1.97e+02 g/l

# Primary_Accession_No:
DB02175

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
867

# PubChem_Substance_ID:
46504875

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02179

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)CC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Malonate
Propanedioic acid

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:52 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Malonic_acid

# pKa_Isoelectric_Point:
2.85 (at 25 °C)

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Z94043

# Drug_Target_1_GenBank_ID_Protein:
1945717

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rsbQ

# Drug_Target_1_Gene_Sequence:
>810 bp
TCACACGTGTGCTTTTAAATAATCGCCGATCAGCTGTATCGTCTCATCTGGATGGCTCAT
ATGAGGGCAATGTCCGCGAGCCTCCATTTGTTTCAGACTGCTATAAGGCAGATGCTGATG
CATATACTTACCTACTGTTGCAGGTGCGATGATATCATCTGCACATTGGAGAATAAGAGA
GGGAACCGTTACCTTCGAAAGATCCTCTCGGTGATCAGAAAAAAACGCCGCTTTCGCGAA
TTGGCGGGCAATGACAGGATCAGTAGAACAAAAACGGCTTTCAAGCTCTTCCTTAATTTC
AGGCCGATCTGGCTGATTCAGAACGGTTGCCGCAAATACAGTCGCCCAGCCGATATAATT
TTTCTCCATCATCTCCAGCAAGCCAAGGAGCTGCTCCTCTTCAAATCCTCCGTAATACTC
AGGCGGATCATTCAAATAGCAAGGAGAAGGCCCCACCATCACCAGATGGGAAAAAAGCTC
CGGGCGGCGGATGGATGCAAGCATCCCAATCAAGGCCCCGACGGAGTGACCCACAAACAC
GGTTTCCTTCAGATCTAAAGCTTCACAAACATCAAGAACATCCTGGGCATAGCCGTCAAG
TGTCTGGTAACGATTCAGGTCATATGCGCGCAAATCTGAATGTCCCGAACCGACGTAATC
AAATAAAATCACCCGATGATCTTCTTCAAAGGCAGGTGCCACGGCATTCCACACGCTTTG
ATCGCATCCAAAACCAGGTGCGAACATGATAGATGCTTTGCCGCTGCCTTTCACCTTCAC
ATGATTTCTAGACAAAATCGCTTCGTTCAT

# Drug_Target_1_General_Function:
Involved in hydrolase activity

# Drug_Target_1_General_References:
10632888	Vijay K, Brody MS, Fredlund E, Price CW: A PP2C phosphatase containing a PAS domain is required to convey signals of energy stress to the sigmaB transcription factor of Bacillus subtilis. Mol Microbiol. 2000 Jan;35(1):180-8.
11591687	Brody MS, Vijay K, Price CW: Catalytic function of an alpha/beta hydrolase is required for energy stress activation of the sigma(B) transcription factor in Bacillus subtilis. J Bacteriol. 2001 Nov;183(21):6422-8.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3490

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
30020

# Drug_Target_1_Name:
Sigma factor sigB regulation protein rsbQ

# Drug_Target_1_Number_of_Residues:
269

# Drug_Target_1_PDB_ID:
1WPR

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00561	Abhydrolase_1

# Drug_Target_1_Protein_Sequence:
>Sigma factor sigB regulation protein rsbQ
MNEAILSRNHVKVKGSGKASIMFAPGFGCDQSVWNAVAPAFEEDHRVILFDYVGSGHSDL
RAYDLNRYQTLDGYAQDVLDVCEALDLKETVFVGHSVGALIGMLASIRRPELFSHLVMVG
PSPCYLNDPPEYYGGFEEEQLLGLLEMMEKNYIGWATVFAATVLNQPDRPEIKEELESRF
CSTDPVIARQFAKAAFFSDHREDLSKVTVPSLILQCADDIIAPATVGKYMHQHLPYSSLK
QMEARGHCPHMSHPDETIQLIGDYLKAHV

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Positive regulator required for energy stress activation of the sigma-B transcription factor. Could be required for rsbP phosphatase activity

# Drug_Target_1_SwissProt_ID:
O07015

# Drug_Target_1_SwissProt_Name:
RSBQ_BACSU

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
5.01

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AE005674

# Drug_Target_2_GenBank_ID_Protein:
24050337

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
panD

# Drug_Target_2_Gene_Sequence:
>369 bp
TCAAGCAACCTGTACCGGAATCGCTTTCGCGGTACGTTTCATTTCATTGTCGCCTTCAAA
ATAGGCGACATTGGGTCGCCAGGTGCGAGCTTCTTCATCTGGCATGGTAACGAAGCTGGC
GATGATGACAATATCGCCGACGCTGGCGCAGTGGGCCGCCGCACCGTTAACAGAAATAAT
TCTCGAACCGCGTTCTGCCGCGATGGCATAAGTGGAGAAACGCTTGCCGTTGGTGACATT
CCAGATATCGATGGCTTCGTTTTCGAGAATACCGGCTGCGTCAAGAAAATCCTGGTCAAT
GGCGCAAGAACCTTCATAGTGCAGGTCCGCATGAGTCACTTTCACGCGGTGGAGTTTGCC
CTGCAGCAT

# Drug_Target_2_General_Function:
Coenzyme transport and metabolism

# Drug_Target_2_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2750

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
13834

# Drug_Target_2_Name:
Aspartate 1-decarboxylase

# Drug_Target_2_Number_of_Residues:
126

# Drug_Target_2_PDB_ID:
1PQE

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02261	Asp_decarbox

# Drug_Target_2_Protein_Sequence:
>Aspartate 1-decarboxylase precursor
MIRTMLQGKLHRVKVTHADLHYEGSCAIDQDFLDAAGILENEAIDIWNVTNGKRFSTYAI
AAERGSRIISVNGAAAHCASVGDIVIIASFVTMPDEEARTWRPNVAYFEGDNEMKRTAKA
IPVQVA

# Drug_Target_2_Reaction:
L-aspartate = beta-alanine + CO2

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
L-aspartate = beta-alanine + CO(2)

# Drug_Target_2_SwissProt_ID:
P0A793

# Drug_Target_2_SwissProt_Name:
PAND_SHIFL

# Drug_Target_2_Synonyms:
Aspartate 1-decarboxylase precursor
Aspartate alpha- decarboxylase
EC 4.1.1.11

# Drug_Target_2_Theoretical_pI:
6.09

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
SRC

# Drug_Target_3_GenBank_ID_Gene:
AL133293

# Drug_Target_3_GenBank_ID_Protein:
10635153

# Drug_Target_3_GeneCard_ID:
SRC

# Drug_Target_3_Gene_Name:
SRC

# Drug_Target_3_Gene_Sequence:
>1611 bp
ATGGGTAGCAACAAGAGCAAGCCCAAGGATGCCAGCCAGCGGCGCCGCAGCCTGGAGCCC
GCCGAGAACGTGCACGGCGCTGGCGGGGGCGCTTTCCCCGCCTCGCAGACCCCCAGCAAG
CCAGCCTCGGCCGACGGCCACCGCGGCCCCAGCGCGGCCTTCGCCCCCGCGGCCGCCGAG
CCCAAGCTGTTCGGAGGCTTCAACTCCTCGGACACCGTCACCTCCCCGCAGAGGGCGGGC
CCGCTGGCCGGTGGAGTGACCACCTTTGTGGCCCTCTATGACTATGAGTCTAGGACGGAG
ACAGACCTGTCCTTCAAGAAAGGCGAGCGGCTCCAGATTGTCAACAACACAGAGGGAGAC
TGGTGGCTGGCCCACTCGCTCAGCACAGGACAGACAGGCTACATCCCCAGCAACTACGTG
GCGCCCTCCGACTCCATCCAGGCTGAGGAGTGGTATTTTGGCAAGATCACCAGACGGGAG
TCAGAGCGGTTACTGCTCAATGCAGAGAACCCGAGAGGGACCTTCCTCGTGCGAGAAAGT
GAGACCACGAAAGGTGCCTACTGCCTCTCAGTGTCTGACTTCGACAACGCCAAGGGCCTC
AACGTGAAGCACTACAAGATCCGCAAGCTGGACAGCGGCGGCTTCTACATCACCTCCCGC
ACCCAGTTCAACAGCCTGCAGCAGCTGGTGGCCTACTACTCCAAACACGCCGATGGCCTG
TGCCACCGCCTCACCACCGTGTGCCCCACGTCCAAGCCGCAGACTCAGGGCCTGGCCAAG
GATGCCTGGGAGATCCCTCGGGAGTCGCTGCGGCTGGAGGTCAAGCTGGGCCAGGGCTGC
TTTGGCGAGGTGTGGATGGGGACCTGGAACGGTACCACCAGGGTGGCCATCAAAACCCTG
AAGCCTGGCACGATGTCTCCAGAGGCCTTCCTGCAGGAGGCCCAGGTCATGAAGAAGCTG
AGGCATGAGAAGCTGGTGCAGTTGTATGCTGTGGTTTCAGAGGAGCCCATTTACATCGTC
ACGGAGTACATGAGCAAGGGGAGTTTGCTGGACTTTCTCAAGGGGGAGACAGGCAAGTAC
CTGCGGCTGCCTCAGCTGGTGGACATGGCTGCTCAGATCGCCTCAGGCATGGCGTACGTG
GAGCGGATGAACTACGTCCACCGGGACCTTCGTGCAGCCAACATCCTGGTGGGAGAGAAC
CTGGTGTGCAAAGTGGCGGACTTTGGGCTGGCTCGGCTCATTGAAGACAATGAGTACACG
GCGCGGCAAGGTGCCAAATTCCCCATCAAGTGGACGGCTCCAGAAGCTGCCCTCTATGGC
CGCTTCACCATCAAGTCGGACGTGTGGTCCTTCGGGATCCTGCTGACTGAGCTCACCACA
AAGGGACGGGTGCCCTACCCTGGGATGGTGAACCGCGAGGTGCTGGACCAGGTGGAGCGG
GGCTACCGGATGCCCTGCCCGCCGGAGTGTCCCGAGTCCCTGCACGACCTCATGTGCCAG
TGCTGGCGGAAGGAGCCTGAGGAGCGGCCCACCTTCGAGTACCTGCAGGCCTTCCTGGAG
GACTACTTCACGTCCACCGAGCCCCAGTACCAGCCCGGGGAGAACCTCTAG

# Drug_Target_3_General_Function:
Involved in protein kinase activity

# Drug_Target_3_General_References:
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
12415108	Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ: Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14783-8. Epub 2002 Nov 1.
2581127	Parker RC, Mardon G, Lebo RV, Varmus HE, Bishop JM: Isolation of duplicated human c-src genes located on chromosomes 1 and 20. Mol Cell Biol. 1985 Apr;5(4):831-8.
2582238	Anderson SK, Gibbs CP, Tanaka A, Kung HJ, Fujita DJ: Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60c-src. Mol Cell Biol. 1985 May;5(5):1122-9.
2681803	Pyper JM, Bolen JB: Neuron-specific splicing of C-SRC RNA in human brain. J Neurosci Res. 1989 Sep;24(1):89-96.
3299057	Tanaka A, Gibbs CP, Arthur RR, Anderson SK, Kung HJ, Fujita DJ: DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol. 1987 May;7(5):1978-83.
7532003	Xu RX, Word JM, Davis DG, Rink MJ, Willard DH Jr, Gampe RT Jr: Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide. Biochemistry. 1995 Feb 21;34(7):2107-21.
9024657	Xu W, Harrison SC, Eck MJ: Three-dimensional structure of the tyrosine kinase c-Src. Nature. 1997 Feb 13;385(6617):595-602.
9174343	Charifson PS, Shewchuk LM, Rocque W, Hummel CW, Jordan SR, Mohr C, Pacofsky GJ, Peel MR, Rodriguez M, Sternbach DD, Consler TG: Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study. Biochemistry. 1997 May 27;36(21):6283-93.

# Drug_Target_3_HGNC_ID:
11283

# Drug_Target_3_HPRD_ID:
01819

# Drug_Target_3_ID:
933

# Drug_Target_3_Locus:
20q12-q13

# Drug_Target_3_Molecular_Weight:
59704

# Drug_Target_3_Name:
Proto-oncogene tyrosine-protein kinase Src

# Drug_Target_3_Number_of_Residues:
535

# Drug_Target_3_PDB_ID:
2SRC

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00017	SH2
PF00018	SH3_1
PF07714	Pkinase_Tyr

# Drug_Target_3_Protein_Sequence:
>Proto-oncogene tyrosine-protein kinase Src
GSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEP
KLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDW
WLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESE
TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLC
HRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK
PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL
RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA
RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG
YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL

# Drug_Target_3_Reaction:
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
P12931

# Drug_Target_3_SwissProt_Name:
SRC_HUMAN

# Drug_Target_3_Synonyms:
EC 2.7.10.2
c- Src
p60-Src
pp60c-src

# Drug_Target_3_Theoretical_pI:
7.47

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
AL939108

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
SCO1207

# Drug_Target_4_Gene_Sequence:
>1215 bp
ATGACTGAAGAAACGATTTCCCAGGCCGTGCCACCCGTCCGGGACTGGCCGGCCGTCGAC
CTTCCCGGCAGCGACTTCGACCCGGTGCTGACCGAGCTGATGCGCGAGGGTCCCGTCACC
CGGATCTCGCTGCCCAACGGCGAGGGCTGGGCCTGGCTCGTGACCCGCCACGACGACGTC
CGCCTGGTCACCAACGACCCCCGGTTCGGGCGCGAGGCCGTCATGGACCGCCAGGTCACC
CGGCTGGCCCCGCACTTCATCCCGGCGCGCGGCGCGGTGGGCTTCCTGGACCCGCCCGAC
CACACCCGGCTGCGCCGCTCGGTGGCCGCGGCCTTCACCGCGCGGGGCGTGGAGCGGGTG
CGCGAGCGGTCCCGGGGCATGCTCGACGAGCTGGTCGACGCCATGCTGAGGGCCGGTCCG
CCCGCCGACCTCACCGAGGCGGTGCTGAGCCCGTTCCCCATCGCGGTGATCTGCGAGCTG
ATGGGTGTGCCGGCCACCGACCGGCACTCCATGCACACCTGGACCCAGCTGATCCTGTCC
TCCTCGCACGGCGCCGAGGTCAGCGAGCGGGCCAAGAACGAGATGAACGCCTACTTCTCG
GATCTCATCGGGCTCCGCTCCGACAGCGCGGGCGAGGACGTCACCTCGCTGCTGGGTGCC
GCCGTGGGGCGGGACGAGATCACGCTGTCGGAGGCCGTCGGGCTCGCGGTGCTGCTCCAG
ATCGGCGGCGAGGCGGTCACCAACAACAGCGGGCAGATGTTCCACCTGCTGCTGAGCCGC
CCGGAGCTGGCCGAACGCCTGCGCTCCGAGCCGGAGATCCGCCCCCGGGCCATCGACGAG
CTGCTGCGCTGGATCCCGCACCGCAACGCCGTGGGGCTGTCCCGGATCGCCCTGGAGGAC
GTGGAGATCAAGGGGGTGCGGATCCGCGCGGGCGACGCCGTCTACGTCTCGTACCTGGCG
GCCAACCGCGACCCGGAGGTGTTCCCCGACCCGGACCGCATCGACTTCGAGCGCTCCCCC
AACCCGCACGTCTCCTTCGGCTTCGGCCCGCACTACTGTCCCGGCGGCATGCTGGCGCGG
CTGGAGTCGGAGCTGCTCGTCGACGCGGTCCTGGACCGCGTGCCGGGGCTGAAGCTCGCG
GTGGCGCCGGAGGACGTGCCCTTCAAGAAGGGTGCGCTGATCCGCGGGCCCGAGGCCCTG
CCGGTGACGTGGTGA

# Drug_Target_4_General_Function:
Involved in monooxygenase activity

# Drug_Target_4_General_References:
12000953	Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 2002 May 9;417(6885):141-7.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
4608

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
44355

# Drug_Target_4_Name:
Putative cytochrome P450

# Drug_Target_4_Number_of_Residues:
404

# Drug_Target_4_PDB_ID:
1T93

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_4_Protein_Sequence:
>Putative cytochrome P450
MTEETISQAVPPVRDWPAVDLPGSDFDPVLTELMREGPVTRISLPNGEGWAWLVTRHDDV
RLVTNDPRFGREAVMDRQVTRLAPHFIPARGAVGFLDPPDHTRLRRSVAAAFTARGVERV
RERSRGMLDELVDAMLRAGPPADLTEAVLSPFPIAVICELMGVPATDRHSMHTWTQLILS
SSHGAEVSERAKNEMNAYFSDLIGLRSDSAGEDVTSLLGAAVGRDEITLSEAVGLAVLLQ
IGGEAVTNNSGQMFHLLLSRPELAERLRSEPEIRPRAIDELLRWIPHRNAVGLSRIALED
VEIKGVRIRAGDAVYVSYLAANRDPEVFPDPDRIDFERSPNPHVSFGFGPHYCPGGMLAR
LESELLVDAVLDRVPGLKLAVAPEDVPFKKGALIRGPEALPVTW

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
Q9FCA6

# Drug_Target_4_SwissProt_Name:
Q9FCA6_STRCO

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
5.02

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Nucleus

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
SNRPA

# Drug_Target_5_GenBank_ID_Gene:
M60784

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
SNRPA

# Drug_Target_5_Gene_Sequence:
>849 bp
ATGGCAGTTCCCGAGACCCGCCCTAACCACACTATTTATATCAACAACCTCAATGAGAAG
ATCAAGAAGGATGAGCTAAAAAAGTCCCTGTACGCCATCTTCTCCCAGTTTGGCCAGATC
CTGGATATCCTGGTATCACGGAGCCTGAAGATGAGGGGCCAGGCCTTTGTCATCTTCAAG
GAGGTCAGCAGCGCCACCAACGCCCTGCGCTCCATGCAGGGTTTCCCTTTCTATGACAAA
CCTATGCGTATCCAGTATGCCAAGACCGACTCAGATATCATTGCCAAGATGAAAGGCACC
TTCGTGGAGCGGGACCGCAAGCGGGAGAAGAGGAAGCCCAAGAGCCAGGAGACCCCGGCC
ACCAAGAAGGCTGTGCAAGGCGGGGGAGCCACCCCCGTGGTGGGGGCTGTCCAGGGGCCT
GTCCCGGGCATGCCGCCGATGACTCAGGCGCCCCGCATTATGCACCACATGCCGGGCCAG
CCGCCCTACATGCCGCCCCCTGGTATGATCCCCCCGCCAGGCCTTGCACCTGGCCAGATC
CCACCAGGGGCCATGCCCCCGCAGCAGCTTATGCCAGGACAGATGCCCCCTGCCCAGCCT
CTTTCTGAGAATCCACCGAATCACATCTTGTTCCTCACCAACCTGCCAGAGGAGACCAAC
GAGCTCATGCTGTCCATGCTTTTCAATCAGTTCCCTGGCTTCAAGGAGGTCCGTCTGGTA
CCCGGGCGGCATGACATCGCCTTCGTGGAGTTTGACAATGAGGTACAGGCAGGGGCAGCT
CGCGATGCCCTGCAGGGCTTTAAGATCACGCAGAACAACGCCATGAAGATCTCCTTTGCC
AAGAAGTAG

# Drug_Target_5_General_Function:
Involved in nucleotide binding

# Drug_Target_5_General_References:
1826055	Hoffman DW, Query CC, Golden BL, White SW, Keene JD: RNA-binding domain of the A protein component of the U1 small nuclear ribonucleoprotein analyzed by NMR spectroscopy is structurally similar to ribosomal proteins. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2495-9.
1831431	Nelissen RL, Sillekens PT, Beijer RP, Geurts van Kessel AH, van Venrooij WJ: Structure, chromosomal localization and evolutionary conservation of the gene encoding human U1 snRNP-specific A protein. Gene. 1991 Jun 30;102(2):189-96.
2147232	Nagai K, Oubridge C, Jessen TH, Li J, Evans PR: Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A. Nature. 1990 Dec 6;348(6301):515-20.
2962859	Sillekens PT, Habets WJ, Beijer RP, van Venrooij WJ: cDNA cloning of the human U1 snRNA-associated A protein: extensive homology between U1 and U2 snRNP-specific proteins. EMBO J. 1987 Dec 1;6(12):3841-8.
7984237	Oubridge C, Ito N, Evans PR, Teo CH, Nagai K: Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin. Nature. 1994 Dec 1;372(6505):432-8.
8070414	Howe PW, Nagai K, Neuhaus D, Varani G: NMR studies of U1 snRNA recognition by the N-terminal RNP domain of the human U1A protein. EMBO J. 1994 Aug 15;13(16):3873-81.
8602269	Allain FH, Gubser CC, Howe PW, Nagai K, Neuhaus D, Varani G: Specificity of ribonucleoprotein interaction determined by RNA folding during complex formulation. Nature. 1996 Apr 18;380(6575):646-50.
9848648	Lutz CS, Cooke C, O'Connor JP, Kobayashi R, Alwine JC: The snRNP-free U1A (SF-A) complex(es): identification of the largest subunit as PSF, the polypyrimidine-tract binding protein-associated splicing factor. RNA. 1998 Dec;4(12):1493-9.

# Drug_Target_5_HGNC_ID:
HGNC:11151

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4609

# Drug_Target_5_Locus:
19q13.1

# Drug_Target_5_Molecular_Weight:
31280

# Drug_Target_5_Name:
U1 small nuclear ribonucleoprotein A

# Drug_Target_5_Number_of_Residues:
282

# Drug_Target_5_PDB_ID:
1FHT

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00076	RRM_1

# Drug_Target_5_Protein_Sequence:
>U1 small nuclear ribonucleoprotein A
MAVPETRPNHTIYINNLNEKIKKDELKKSLYAIFSQFGQILDILVSRSLKMRGQAFVIFK
EVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMKGTFVERDRKREKRKPKSQETPA
TKKAVQGGGATPVVGAVQGPVPGMPPMTQAPRIMHHMPGQPPYMPPPGMIPPPGLAPGQI
PPGAMPPQQLMPGQMPPAQPLSENPPNHILFLTNLPEETNELMLSMLFNQFPGFKEVRLV
PGRHDIAFVEFDNEVQAGAARDALQGFKITQNNAMKISFAKK

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Binds stem loop II of U1 snRNA. It is the first snRNP to interact with pre-mRNA. This interaction is required for the subsequent binding of U2 snRNP and the U4/U6/U5 tri-snRNP. In a snRNP-free form (SF-A) may be involved in coupled pre-mRNA splicing and polyadenylation process

# Drug_Target_5_SwissProt_ID:
P09012

# Drug_Target_5_SwissProt_Name:
SNRPA_HUMAN

# Drug_Target_5_Synonyms:
U1 snRNP protein A
U1-A
U1A protein

# Drug_Target_5_Theoretical_pI:
10.50

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasmic

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AF012735

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
Not Available

# Drug_Target_6_Gene_Sequence:
>1245 bp
ATGATCTCACTCGCCGACCTCCAGCGCCGCATCGAAACGGGCGAGCTGTCGCCTAACGCA
GCCATCGCCCAGTCGCACGCGGCGATCGAGGCGCGGGAGAAGGAGGTCCATGCCTTCGTC
CGCCACGACAAGTCGGCAAGAGCGCAAGCCTCCGGCCCGCTGCGCGGTATCGCCGTCGGC
ATCAAGGACATCATCGACACCGCCAACATGCCCACCGAGATGGGCTCGGAGATCTATCGC
GGCTGGCAGCCGCGCAGCGACGCGCCTGTCGTGATGATGCTGAAGCGGGCGGGGGCCACC
ATCATCGGCAAGACCACCACCACGGCGTTCGCCTCGCGCGATCCGACGGCGACGCTCAAT
CCGCACAATACCGGCCATTCCCCGGGCGGCTCGTCCTCGGGCTCGGCGGCGGCGGTCGGC
GCCGGCATGATCCCGCTGGCGCTGGGCACCCAGACCGGCGGCTCGGTGATCCGGCCCGCC
GCCTATTGCGGGACGGCCGCGATCAAGCCGTCGTTCCGCATGCTGCCGACGGTCGGCGTG
AAGTGCTATTCGTGGGCGCTCGACACGGTCGGCCTGTTCGGCGCGCGCGCGGAGGATCTC
GCGCGCGGACTGCTGGCGATGACCGGCCGCAGCGAATTCTCCGGCATCGTCCCGGCCAAG
GCACCGCGCATCGGCGTGGTCAGGCAGGAGTTCGCCGGCGCTGTCGAGCCGGCGGCCGAG
CAGGGCCTGCAAGCCGCGATCAAGGCGGCCGAGCGGGCCGGGGCCAGTGTTCAGGCCATC
GATCTGCCCGAGGCGGTGCATGAGGCCTGGCGCATCCATCCCATCATCCAGGATTTCGAG
GCGCATCGCGCGCTCGCCTGGGAGTTTTCCGAGCATCACGACGAGATCGCGCCGATGCTG
CGCGCCAGTCTCGATGCGACGGTCGGGCTCACGCCGAAGGAATATGACGAGGCGCGCCGG
ATCGGCCGCCGTGGCCGCCGCGAGCTTGGCGAAGTGTTCGAGGGCGTCGACGTGCTCTTG
ACCTATTCGGCGCCGGGCACCGCGCCGGCCAAGGCTCTCGCGAGCACCGGCGACCCTCGC
TACAACCGGCTCTGGACGCTGATGGGCAATCCTTGCGTCAACGTGCCGGTGCTGAAGGTC
GGTGGCCTGCCGATCGGCGTGCAGGTGATCGCGCGCTTCGGCAACGACGCACATGCGCTT
GCGACGGCGTGGTTCCTGGAGGATGCGCTGGCGAAATCAGGCTAG

# Drug_Target_6_General_Function:
Involved in carbon-nitrogen ligase activity, with glutamine as amido-N-donor

# Drug_Target_6_General_References:
12597275	Kaneko T, Nakamura Y, Sato S, Minamisawa K, Uchiumi T, Sasamoto S, Watanabe A, Idesawa K, Iriguchi M, Kawashima K, Kohara M, Matsumoto M, Shimpo S, Tsuruoka H, Wada T, Yamada M, Tabata S: Complete genomic sequence of nitrogen-fixing symbiotic bacterium Bradyrhizobium japonicum USDA110. DNA Res. 2002 Dec 31;9(6):189-97.
12711609	Shin S, Yun YS, Koo HM, Kim YS, Choi KY, Oh BH: Characterization of a novel Ser-cisSer-Lys catalytic triad in comparison with the classical Ser-His-Asp triad. J Biol Chem. 2003 Jul 4;278(27):24937-43. Epub 2003 Apr 23.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
4600

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
43682

# Drug_Target_6_Name:
Malonamidase E2

# Drug_Target_6_Number_of_Residues:
414

# Drug_Target_6_PDB_ID:
1OBL

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF01425	Amidase

# Drug_Target_6_Protein_Sequence:
>Malonamidase E2
MISLADLQRRIETGELSPNAAIAQSHAAIEAREKEVHAFVRHDKSARAQASGPLRGIAVG
IKDIIDTANMPTEMGSEIYRGWQPRSDAPVVMMLKRAGATIIGKTTTTAFASRDPTATLN
PHNTGHSPGGSSSGSAAAVGAGMIPLALGTQTGGSVIRPAAYCGTAAIKPSFRMLPTVGV
KCYSWALDTVGLFGARAEDLARGLLAMTGRSEFSGIVPAKAPRIGVVRQEFAGAVEPAAE
QGLQAAIKAAERAGASVQAIDLPEAVHEAWRIHPIIQDFEAHRALAWEFSEHHDEIAPML
RASLDATVGLTPKEYDEARRIGRRGRRELGEVFEGVDVLLTYSAPGTAPAKALASTGDPR
YNRLWTLMGNPCVNVPVLKVGGLPIGVQVIARFGNDAHALATAWFLEDALAKSG

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q9ZIV5

# Drug_Target_6_SwissProt_Name:
Q9ZIV5_BRAJA

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
8.13

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AE008771

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
rimL

# Drug_Target_7_Gene_Sequence:
>540 bp
TTAATCCGCATCAATAATGCGGGCATACATATTAACGTCGTGATAGTCGCCGTTAAGATA
CTCCGCCTGCTTCATACAGCCCTCCAGCGTAAAATGGTTGCGCCGTGCGACTGCGTTACT
GGCCTGATTATCAACGCGGCATTTAATGACGAAGCGCCGAATATCGCCGCGCCGGGCATA
ATGTGTCATCAGCGCCTGTAATGATTGCGACATTATCCCTTGTCCCTGGAAGGACTCATC
CAGCCAGTAACCGATATAGGCGGCTTTGTTTATCGGTTCGATGGCATTAAATGAGAGTAC
GCCTGCCATCTCATTCTGGCAGAAAATCAGGTACATTTTGGCGTAACCACGCTGGTGCAA
CAGTATATTACCCTGCACATGCTTACGCGTTTCCTCCTGCGACGTGACATATTGCGGCCA
GTCGAGCGACTGTTGTAGCCACGCTTTGTTTTTGAGTACCAGTTGGTGCAGCGCCGGAAC
ATGACTTTCATCTGCCGCTCGCAGTTCCAGCGTCGTGCTAACAGGAATAATTTCCACCAT

# Drug_Target_7_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_7_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
4563

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
20606

# Drug_Target_7_Name:
Acetyl transferase

# Drug_Target_7_Number_of_Residues:
179

# Drug_Target_7_PDB_ID:
1S7N

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_7_Protein_Sequence:
>Acetyl transferase
MVEIIPVSTTLELRAADESHVPALHQLVLKNKAWLQQSLDWPQYVTSQEETRKHVQGNIL
LHQRGYAKMYLIFCQNEMAGVLSFNAIEPINKAAYIGYWLDESFQGQGIMSQSLQALMTH
YARRGDIRRFVIKCRVDNQASNAVARRNHFTLEGCMKQAEYLNGDYHDVNMYARIIDAD

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not Available

# Drug_Target_7_SwissProt_ID:
Q8ZPC0

# Drug_Target_7_SwissProt_Name:
Q8ZPC0_SALTY

# Drug_Target_7_Synonyms:
EC 2.3.1.-

# Drug_Target_7_Theoretical_pI:
7.19

# Drug_Target_7_Transmembrane_Regions:
None

#END_DRUGCARD DB02175
